BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 231567)

  • 1. The use of artificial beta cell in diagnosis and treatment of insulinoma.
    Raptis S; Zoupas C; Dimitriadis G; Moulopoulos S
    Horm Metab Res Suppl; 1979; (8):169-72. PubMed ID: 231567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial beta-cell application in two cases of insulinoma: a different pattern in beta-cell adenoma and carcinoma.
    Brunetti P; Santeusanio F; Puxeddu A; Massi-Benedetti M; Calabrese G; Angeletti G; Bueti A; Scionti L; De Angelis M
    Horm Metab Res Suppl; 1979; (8):173-7. PubMed ID: 231568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
    Altomare E; Moulin JP; Tavares S; Bourelly N; Lassmann V; Vague P
    Horm Metab Res Suppl; 1979; (8):110-5. PubMed ID: 395065
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tolbutamide plus somatostatin test in the diagnosis of insulinomas].
    Jara Albarrán A; Caballero Asensi A; García Peris P; Coste A; Toledano E; Gorospe C; Caviola E; Palacios Mateos JM
    Rev Clin Esp; 1982 Jan; 164(2):105-9. PubMed ID: 6124027
    [No Abstract]   [Full Text] [Related]  

  • 5. [Secreting langerhansian insulinoma. Clinical, biological, arteriographical and ultrastructural study of a case].
    Rochiccioli P; Delsol G; Juskiewinski S; Ghisolfi J; Ribot C; Gabarou JP; Fabre J; Dalous A
    Arch Fr Pediatr; 1971 Dec; 28(10):1041-56. PubMed ID: 4338621
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of an artificial beta cell in surgery.
    Horwitz DL; Schwartz SS
    Horm Metab Res Suppl; 1979; (8):156-8. PubMed ID: 395072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the glucose clamp technique for confirmation of insulinoma autonomous hyperinsulinism.
    Gin H; Brottier E; Dupuy B; Guillaume D; Ponzo J; Aubertin J
    Arch Intern Med; 1987 May; 147(5):985-7. PubMed ID: 3034180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of glucose-controlled insulin infusion system for improvement of subcutaneous insulin regimen.
    Irsigler K; Kritz H; Kaspar L; Brändle J; Franetzki M
    Horm Metab Res Suppl; 1979; (8):134-40. PubMed ID: 395070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biochemical diagnosis of insulinoma: correlations between blood glucose, blood insulin and the titer of plasma non-esterified fatty acids during fasting and during various diagnostic tests].
    Gorini M; Ghizzi A; Carlo Stella C; De Caro L
    Minerva Med; 1985 Sep; 76(37):1663-75. PubMed ID: 2995870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anomalous glucose and insulin responses in patients with insulinoma. Caveats for diagnosis.
    Dons RF; Hodge J; Ginsberg BH; Brennan MF; Cryer PE; Kourides IA; Gorden P
    Arch Intern Med; 1985 Oct; 145(10):1861-3. PubMed ID: 2994586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
    Christiansen JS; Svendsen PA; Deckert T
    Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the clinical diagnosis of islet cell adenoma. Clinical experiences and diagnostic procedure in organic hyperinsulism].
    Bottermann P; Schwarz K; Kollmannsberger A; Kopetz K
    Med Klin; 1969 Mar; 64(11):479-88. PubMed ID: 4305727
    [No Abstract]   [Full Text] [Related]  

  • 13. [Atypical case of insulinoma (author's transl)].
    Lucke C; Grögler F; Mitzkat HJ
    Med Klin; 1974 Sep; 69(36):1456-9. PubMed ID: 4373641
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of diabetic ketoacidosis with a computer-controlled bedside monitoring and infusion system.
    Berg G; Sailer D
    Horm Metab Res Suppl; 1979; (8):146-50. PubMed ID: 119698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apropos of a case of severe hypoglycemia. Present possibilities of diagnosis and treatment].
    Fontaine R; Schneegans E; Haarscher A; Levy-Silagy J; Hasselmann JL; Meyer-Lutz ; Dorner M
    Ann Pediatr (Paris); 1968 Oct; 15(10):664-70. PubMed ID: 4304698
    [No Abstract]   [Full Text] [Related]  

  • 16. [Contribution of the artificial pancreas in the diagnosis and surgical treatment of insulinomas].
    Parneix M; Rullier E; Gin H; Roche A
    Ann Chir; 1994; 48(5):421-9. PubMed ID: 7810974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Various tests in the evaluation of islet cell adenomas.
    Schmidt WM; Levey GS; Mintz DH
    JFMA; 1973 Feb; 60(2):21-4. PubMed ID: 4347157
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of the artificial pancreas in the diagnosis and management of an insulinoma (author's transl)].
    Buysschaert M; Lambotte L; Rahier J; Kestens PJ; Lambert AE
    Ann Endocrinol (Paris); 1980; 41(3):227-8. PubMed ID: 6251746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
    Stavljenić A; Granić M; Topić B; Skrabalo Z
    Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood glucose monitoring and computer regulation by means of an artificial endocrine pancreas.
    Kruse-Jarres JD; Braun G; Naegele R; Bresch M; Lehmann U
    Horm Metab Res Suppl; 1979; (8):42-5. PubMed ID: 395088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.